News
ASAM Announces New Board of Directors for 2025-2027 Term
Rockville, MD (Jan. 24, 2025) – The American Society of Addiction Medicine (ASAM) today announced its new Board of Directors for the 2025-2027 term. The newly elected officers will guide ASAM's overarching strategy to advance its vision of a future when addiction prevention, treatment, remission, and recovery are accessible to all.
The new members of the Board of Directors will officially begin their terms at the end of the ASAM 56th Annual Conference beginning on April 27, 2025, in Denver, CO. Stephen M. Taylor, MD, MPH, DFAPA, DFASAM, who was elected president-elect in 2022 for the 2023-2025 term, will assume his role as president of ASAM at this time.
2024 election results:
Board Executive Officers
President-Elect
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM
Vice-President
Cara A. Poland, MD, MEd, FACP, DFASAM
Treasurer
Jason D. Kirby, DO, MBA, FASAM
Secretary
Regional Directors
Regional I Director
Kristine Torres-Lockhart, MD, FASAM
Regional II Director
Itai Danovitch, MD, MBA, DFAPA, DFASAM
Regional III Director
Barbara L. Rosenthal, MD, FAAFP, DFASAM
Regional IV Director
Regional V Director
Regional VI Director
Regional VII Director
Regional VIII Director
Regional IX Director
Regional X Director
# # #
About the American Society of Addiction Medicine
The American Society of Addiction Medicine (ASAM), founded in 1954, is a professional society representing over 8,000 physicians, clinicians, and associated professionals in the field of addiction medicine. ASAM is dedicated to increasing access and improving the quality of addiction treatment, educating physicians and the public, supporting research and prevention, and promoting the appropriate role of physicians in the care of patients with addiction. For more information, visit www.ASAM.org.
